[1]
Severina, A.I., Kavraiskyi, D.P., Kovalevska, I.V., Shtrygol’, S.Y., Ruban, E.A. and Georgiyants, V.A. 2017. Dependence of anticonvulsant activity of 1-aryl-1, 5-dihydro-4H-pyrazole (3,4-d) pyrimidine-4-one derivatives on biopharmaceutical factors. International Journal of Basic & Clinical Pharmacology. 6, 7 (Jun. 2017), 1552–1559. DOI:https://doi.org/10.18203/2319-2003.ijbcp20172715.